Back to trial detailsIntake questionnaire
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Applying to Sarah Cannon Research Institute Denver · Denver, Colorado
Answer a few short questions to share with the research team.
0 of 3 answered